Exicure is a stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets.

Exicure

Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.

Exicure, Inc.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 19, 2024 4:33 PM	86bd55cb
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Sep 19, 2024 5:18 PM	35e61511
company summary	general
signals	general	Sep 19, 2024 4:33 PM	8117d771
crunchbase trigger	general	Nov 27, 2024 12:50 PM	dc87192d
crunchbase profile	general
li profile	general
translate crunchbase fundingrounds	general
peers	general	Sep 19, 2024 4:33 PM	f9b6a97e
news basic	general	Sep 19, 2024 4:33 PM	7b0110c1
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:EXICURETX

Exicure

Last Close

10.86

22/11 21:00

Market Cap

2.65M

Beta: -

Volume Today

107.75K

Avg: -